BioCardia, Inc. (BCDA)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 12-31. Amounts in USD.

Revenue Annual

0 500K 1M 1.5M FY16: 576K FY17: 479K FY18: 625K FY19: 710K FY20: 145K FY21: 1M FY22: 1.4M FY23: 477K FY24: 58K FY25: 0 FY16 FY17 FY18 FY19 FY20 FY21 FY22 FY23 FY24 FY25

Gross Profit Annual

0 25K 50K 75K FY10: 0 FY11: 12K FY12: 62K FY10 FY11 FY12

Operating Income Annual

-18M -12M -6M 0 6M 12M 18M FY16: -7.6M FY17: -12.4M FY18: -14.1M FY19: -14.2M FY20: -15.5M FY21: -12.6M FY22: -11.9M FY23: -11.6M FY24: -8M FY25: -8.3M FY16 FY17 FY18 FY19 FY20 FY21 FY22 FY23 FY24 FY25

Net Income Annual

-18M -12M -6M 0 6M 12M 18M FY16: -10.3M FY17: -12.3M FY18: -14M FY19: -14.7M FY20: -15M FY21: -12.6M FY22: -11.9M FY23: -11.6M FY24: -7.9M FY25: -8.2M FY16 FY17 FY18 FY19 FY20 FY21 FY22 FY23 FY24 FY25

Cost of Revenue Annual

0 300K 600K 900K FY10: 0 FY11: 0 FY12: 0 FY16: 746K FY17: 690K FY18: 517K FY19: 358K FY20: 4K FY21: 0 FY10 FY11 FY12 FY16 FY17 FY18 FY19 FY20 FY21

Operating Cash Flow Annual

-15M -10M -5M 0 5M 10M 15M FY16: -5.5M FY17: -8.7M FY18: -11.1M FY19: -9.4M FY20: -12.4M FY21: -10.4M FY22: -10.6M FY23: -10M FY24: -7.9M FY25: -7.4M FY16 FY17 FY18 FY19 FY20 FY21 FY22 FY23 FY24 FY25

Free Cash Flow Annual

-15M -10M -5M 0 5M 10M 15M FY15: -7.1M FY17: -8.8M FY18: -11.1M FY19: -9.6M FY20: -12.4M FY21: -10.5M FY22: -10.6M FY23: -10M FY24: -7.9M FY25: -7.4M FY15 FY17 FY18 FY19 FY20 FY21 FY22 FY23 FY24 FY25

Operating cash flow minus capital expenditure.

Shares Outstanding Annual

0 80M 160M 240M FY11: 230.3M FY12: 230.3M FY13: 230.3M FY14: 230.3M FY15: 230.3M FY21: 16.9M FY22: 17.7M FY23: 1.4M FY24: 2.7M FY25: 6.7M FY11 FY12 FY13 FY14 FY15 FY21 FY22 FY23 FY24 FY25

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

EPS TTM

-7.50 -5.00 -2.50 0.00 2.50 5.00 7.50 Q4 '14: 0.00 Q1 '15: 0.00 Q2 '15: 0.00 Q3 '15: 0.00 Q4 '15: -4.29 Q4 '17: -2.91 Q1 '18: -2.92 Q2 '18: -3.60 Q3 '18: -4.35 Q4 '18: -2.53 Q1 '19: -3.30 Q2 '19: -3.31 Q3 '19: -3.11 Q4 '19: -2.74 Q1 '20: -2.55 Q2 '20: -2.24 Q3 '20: -1.91 Q4 '20: -1.58 Q1 '21: -1.09 Q2 '21: -0.83 Q3 '21: -0.69 Q4 '21: -0.75 Q1 '22: -0.76 Q2 '22: -0.70 Q3 '22: -0.71 Q4 '22: -0.66 Q1 '23: -0.64 Q2 '23: -3.02 Q3 '23: -4.64 Q4 '23: -5.80 Q1 '24: -6.98 Q2 '24: -5.34 Q3 '24: -4.16 Q4 '24: -3.09 Q1 '25: -2.33 Q2 '25: -1.85 Q3 '25: -1.48 Q4 '25: -1.29 Q1 '26: -0.91 Q2 '26: -0.64 Q4 '15 Q4 '18 Q1 '20 Q2 '21 Q3 '22 Q4 '23 Q1 '25 Q2 '26

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.